Plasma miR-122 and miR-3149 Potentially Novel Biomarkers for Acute Coronary Syndrome.
We evaluated the potentiality of plasma microRNAs (miRNAs, or miRs) that were considered as novel biomarkers for acute coronary syndrome (ACS), including acute myocardial infarction (AMI) and unstable angina (UA).We initially identified plasma miR-122, -140-3p, -144, -720, -1225-3p, -2861, and -3149...
Main Authors: | Xiangdong Li, Yuejin Yang, Laiyuan Wang, Shubin Qiao, Xiangfeng Lu, Yongjian Wu, Bo Xu, Hongfan Li, Dongfeng Gu |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2015-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4416808?pdf=render |
Similar Items
-
Microvesicle-associated and circulating microRNAs in diabetic dyslipidemia: miR-218, miR-132, miR-143, and miR-21, miR-122, miR-155 have biomarker potential
by: Miruna Nemecz, et al.
Published: (2023-09-01) -
Early diagnostic evaluation of miR-122 and miR-224 as biomarkers for hepatocellular carcinoma
by: Khalda S. Amr, et al.
Published: (2017-12-01) -
Serum levels of miR-29, miR-122, miR-155 and miR-192 are elevated in patients with cholangiocarcinoma.
by: Sven H Loosen, et al.
Published: (2019-01-01) -
miR-155 and miR-122 Expression of Spermatozoa in Obese Subjects
by: Paulina López, et al.
Published: (2018-05-01) -
Metformin decreases miR-122, miR-223 and miR-29a in women with polycystic ovary syndrome
by: Pernille Bækgaard Udesen1, et al.
Published: (2020-12-01)